pyrazole has been researched along with Toxoplasmosis, Cerebral in 1 studies
1H-pyrazole : The 1H-tautomer of pyrazole.
Toxoplasmosis, Cerebral: Infections of the BRAIN caused by the protozoan TOXOPLASMA gondii that primarily arise in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES (see also AIDS-RELATED OPPORTUNISTIC INFECTIONS). The infection may involve the brain diffusely or form discrete abscesses. Clinical manifestations include SEIZURES, altered mentation, headache, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. (From Joynt, Clinical Neurology, 1998, Ch27, pp41-3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rutaganira, FU | 1 |
Barks, J | 1 |
Dhason, MS | 1 |
Wang, Q | 1 |
Lopez, MS | 1 |
Long, S | 1 |
Radke, JB | 1 |
Jones, NG | 1 |
Maddirala, AR | 1 |
Janetka, JW | 1 |
El Bakkouri, M | 1 |
Hui, R | 1 |
Shokat, KM | 1 |
Sibley, LD | 1 |
1 other study available for pyrazole and Toxoplasmosis, Cerebral
Article | Year |
---|---|
Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii.
Topics: Animals; Antiprotozoal Agents; Female; Humans; Male; Mice; Protein Kinase Inhibitors; Protein Kinase | 2017 |